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CHAPTER I 
INTRODUCTION 
Myonecrosis as the result of rattlesnake bite is a well documented 
clinical occurrence (1-3). Although most victims of snakebite survive, 
such massive local tissue damage can be induced that in a high per-
centage of cases the result is either dysfunction or loss of a finger, 
hand, or other limb. Serious tissue destruction can result from the 
bite of even the youngest snakes (4). Even the treatment of the victim 
with antivenin does not prevent necrosis in most cases (5). Numerous 
assays for myonecrosis have been performed on the venom of various 
species of rattlesnakes. In every study reported, myonecrosis was 
induced in laboratory animals injected with the venom of every species 
investigated (6-10). Despite the clinical consequences and the 
obvious widespread occurrence of myonecrotic components in rattlesnake 
venoms, until recently little work has been done to isolate and 
characterize these muscle damaging proteins of rattlesnake venoms. 
The first isolation of a myonecrotic toxin from a rattlesnake 
venom was reported in 1977 by Cameron and Tu (11). The protein, 
named myotoxin ~' was purified from the venom of the North American 
prairie rattlesnake, Crotalus viridis viridis. With a molecular 
weight of 4621 daltons, myotoxin ~ is composed of 42 amino acid 
residues, six of these half cystines, forming the molecule's three 
disulfide bridges (12). The combination of arginine, lysine, and 
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histidine accounts for 13 of the residues, with a correspondingly 
basic isoelectric point of 9.6 demonstrated by isoelectric focusing. 
The secondary structure of myotoxin !! as determined by circular 
dichroism and raman spectroscopy, shows significant amounts of 
S-sheet and S-turn structures with small areas of random coil and/or 
a-helix (13). 
The pathenogenesis of myotoxin !! has been investigated by 
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Stringer et al. (14) and more recently by Ownby et al. (15). Tissues 
from animals injected with 1.5 µg/g body weight of the pure toxin 
intramuscularly shows partial vacuolization of muscle cells at 6, 12, 
and 24 hours and complete vacuolization and loss of striations at 48 
and 72 hours by light microscopy. No evidence of hemorrhage, hemolysis, 
or damage to connective tissue cells was found. Electron microscopy 
showed dialation of the sacroplasmic reticulium and the perinuclear 
space as the cause of the vacuolization. Other ultrastructural 
features of the affected cells were disintegrated by myofibrils and 
extreme distortion of mitochondria. It was concluded that the 
primary site of action was on the sarcoplasmic reticulum either 
directly or indirectly through the sacrolemma. It was proposed that 
myotoxin !! might affect transport of ions by inhibiting the Na+/K+ 
ATPase. 
Ownby et al. (16) has reported the production of an antibody to 
myotoxin !! from rabbits. The antiserum was reacted with myotoxin .!!, 
in agar-gel double-diffusion plates, and one precipitin line was 
formed. It was also shown that commercial crotalidae antivenin 
contained no myotoxin antibodies. This verifies clinical observations 
that the polyvalent crotalidae antivenin in use is ineffective in 
detering myonecrosis (4). In a later study (17), it was shown that 
the antimyotoxin serum neutralized myotoxin a when mixed with it 
prior to intramuscular injection up to a dose of 0.75 µg/g. 
Another myonecrotic toxin, crotamine, has been isolated from the 
venom of Crotalus durissus terrificus, the South American rattlesnake. 
[The protein was first reported in 1947 (18), and was described as a 
neurotoxin (19). In 1971, however, it was shown that crotamine 
caused depolarization of muscle cell membranes (20). In 1978, 
Cameron and Tu (21) demonstrated that the toxin caused vacuolization 
of muscle cells qualitatively similar to that of myotoxin !! on the 
light microscope level. Chemically, crotamine is strikingly similar 
to myotoxin !!· It is also composed of 42 amino acids, possesses 
three disulfide bonds, and shows an isoelectric point of > 9.0. In 
fact, amino acid sequence studies shows only three amino acid residue 
(differences between the primary structure of crotamine and myotoxin !! . 
(12, 22). 
In 1981, Pool et al. (23) reported the isolation of two myotoxins 
from the venom of Crotalus viridis concolor, the midget faded rattle-
snake of North America. Amino acid analysis indicates 39 amino acid 
residues for myotoxin I and 35 residues for myotoxin II. Both 
proteins exhibit high contents of basic amino acids and isoelectric 
points near 10. Mice injected with either protein exhibited immediate 
symptomology including extreme tonic hypertension of the hind limbs 
and labored breathing. The toxins also demonstrate myonecrosis 
similar to myotox:in !! and crotamine. 
Russell et al. (8) has found a myonecrotic tox:in in the venom of 
Crotalus viridis helleri. The peptide is composed of 43 amino acid 
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residues. Highly significant characteristics it displays are six 
half-cystine residues, a high lysine content, and an NH2-terminal 
tyrosine residue. Only five amino acid substitutions plus an 
additional COOR-terminal residue distinguish it from crotamine 
from Crotalus durissus terrificus. 
Evidence of myotoxins have been shown in two Venezualan rattle-
snake species by Rodriguez and Scannone. Crotalus durissus cum.anensis 
(9) contains a highly basic peptide of approximately 5200 daltons. 
Mice injected with the toxin show the characteristic spastic paralysis 
of a myonecrotic toxin. The venom of Crotalus vegrandis also shows 
evidence of a low molecular weight basic toxin, which shows sympto-
mology identical with that of known myonecrotic toxins (10). 
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Recently, a second myonecrotic component was isolated from the 
venom of Crotalus viridis viridis (24). Named viriditoxin, its 
structure varies radically from the rattlesnake myotoxins discussed 
earlier. It is comprised of approximately 1018 amino acid residues, 
showing a molecular weight of 115,000. The protein has an isoelectric 
point of 4.6, confirming the abundance of acidic amino acid residues. 
The toxin induces myonecrosis similar to myotoxin ~ under the light 
microscope, showing loss of muscle fiber striations and severe vacuoli-
zation of muscle cells. In addition, viriditoxin also produces 
hemorrhage following subcutaneous injections, with a minimum hemorrhagic 
dose of 1.5 µg in 20 gram mice. 
It is the purpose of the present study to isolate and characterize 
the myonecrotic component from the venom of the Central .American rattle-
snake, Crotalus durissus durissus. 
CHAPTER II 
LITERATURE REVIEW 
The Central American rattlesnake, Crotalus durissus durissus, 
or "La Cascabella" as it is known locally, was first described by 
Linnaeus in 1758. It is one of nine rattlesnakes of the durissus 
group, a subdivision of the genus Crotalus. The durissus species, 
one of six in the durissus group, is the only species of rattlesnake, 
either of the genus Crotalus or Sistrusus, that extends south of the 
southern Mexican states. Durissus durissus is thus the only 
rattlesnake found in Central America, with the other member of the 
species, durissus terrificus, the South American rattlesnake, 
occurring no further north than Panama. The distribution of durissus 
durissus has been defined as occurring from southern Mexico, in the 
area of Oaxaca and Vericruz, to the more arid regions of Central 
America through Guatemala, Salvadore, Honduras, and the west coasts 
of Nicaragua and Costa Rica (25). 
The venom of C. d. durissus has been subjected to numerous 
biochemical and physiological assays by various investigators. 
In a study of 17 snake venoms, Friederich and Tu (26) studied the 
role of metals in hemorrhagic, esterase, and proteolytic activities. 
It was found that .f· ~· durissus venom contained calcium, zinc, 
magnesium, sodium, and potassium, as did the other rattlesnake venoms 
tested. The venom showed a lack of copper, manganese, and iron, 
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metals present in Viperdae, Elapidae and some Crotalidae venoms, but 
lacking in the Crotalus genus. When crude venom was dialyzed in EDTA 
treated dialysis tubing against distilled water, hemorrhagic activity 
ceased. Addition of manganese restored 15% activity of the untreated 
venom, zinc restored 4% activity, and added calcium had no effect. 
Enzymatic activity of protease was measured with casein as substrate; 
TAME and BAEE were used in determination of esterase activity. EDTA 
treatment of the crude venom had no effect on esterase activity, while 
proteolytic activity fell to a fraction of non EDTA-treated activity. 
Addition of calcium, zinc, or magnesium had little effect on the 
restoration of activity. No Ln50 was found for the treated or 
untreated venom. 
In a related study, Kocholaty et al. (27) investigated enzymatic 
activities and toxicities of venoms from various species in the 
Elapidae, Viperidae, and Crotalidae families. C. d. durissus venom 
showed a 75% protein content by the Biuret method. Toxicity levels 
were found to be 667 and 1244 µg/kg for injections by the i.p. and 
i.v. routes, respectively. Levels of amino acid oxidase and phos-
phodiesterase activities were found to be close with that reported 
for other venoms of the Crotalidae family. However, phospholipase A 
and proteinase (casein) levels were lower than that of the majority 
of the crotalids. Marked trypsin activity was found, using BAPNA and 
TAME as substrates. 
In a study by Bolanos (28), it was again shown that injection of 
the crude venom by the i.p. route to be two to three times as toxic 
as was via i.v. injection, an inconsistency when compared to similar 
experiments with other venoms, showing a lower LD 50 for intravenous 
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injections. The study also showed the average venom yield per speciman 
for Crotalus durissus durissus to be 76.8 mg. 
Denson et al. (29) has characterized the coagulant activity of 
a number of snake venoms. The purpose of the study was to classify 
the activity into one of four general groups: (1) Activation of 
factor X of blood coagulation reactions; (2) Conversion of pro-
thrombin to thrombin in the presence of factor V; (3) Conversion 
of prothrombin to thrombin in the absence of factor V; and (4) The 
direct conversion of f ibrinogen to fibrin, characteristic of 
Crotalus durissus terrificus venom. Crotalus durissus durissus 
venom showed the ability to clot citrated fresh human plasma at 3, 
6, and 9 minutes. It also showed fibrinolytic activity, but no 
esterolytic activity. The clotting time of bovine fibrinogen 
increased as a function of crude venom dilution, thus indicating 
the ability of the venom to convert fibrinogen to fibrin (thrombin-
like activity). The venom did fail to show the ability to activate 
factor X or activate prothrombin, regardless of the absence or 
presence of factor V. 
Kocholaty et al. (30) did a study on the innnunogenic response 
of Crotalus durissus durissus venom following photooxidative detoxi-
fication. Non-photooxidized venom showed proteolytic, esterolytic, 
and phospholipase activities, as found in other studies. The LD50 
values were 1. 20 g/kg for i. v. injection, and O. 6 7 g/kg for inter-
peritoneal injection, as shown in other studies. Crude venom was 
then photooxidized under visible light in a respirometer in the 
presence of methylene blue. It was found that the three enzymatic 
activities decreased and the LD50 dosage increased as a function of 
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exposure to the procedure. Rabbits were immunized with photooxidized 
venom, and the resulting gamma-globulins isolated. It was found that 
the gamma-globulins gave a high degree of protection to mice injected 
with crude venom. 
In a study by Sosa et al. (31), it was found that Crotalus 
durissus durissus venom does not contain a direct hemolytic factor, an 
agent which by itself can hemolyze a red blood cell. Results did show 
the presence of an indirect lytic factor, an activity which can be 
stimulated by the presence of lysophosphatidic derivatives. This 
phenomena has been identified as phospholipase activity. However, 
the investigators concluded that there was an indication that other 
agents might be involved in the hemolytic process. 
The presence of myonecrotic component(s) in Crotalus durissus 
durissus venom has been documented. Homma and Tu (6) have studied 
the morphology of local tissue damage created by the venoms of 37 
snakes, nine of them rattlesnakes, in laboratory mice. It was demon-
strated that C. ~· durissus venom caused a 17% swelling of the 
injected leg. There was also evidence of hemorrhage near the sight 
of injection. Muscle necrosis was divided into three groups: (1) co-
agulative necrosis; (2) myolysis; and (3) mixed type, showing 
evidence of both coagulative necrosis and myolysis. Crotalus durissus 
durissus induced the mixed type of necrosis, as did the venom of 
Crotalus durissus terrificus. Arterial lesions were also induced, 
which showed several prominent histological changes: (1) disinte-
gration of the endothelial cells; (2) leucocytic infiltration beneath 
the endothelium; (3) necrosis and disappearance of the smooth muscle 
fibers in the media, (4) hemorrhage and insudation of a fibrin-like 
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substance into the subendothelial and medial layer, and (5) formation 
of mural thrombi. 
Myonecrotic action in the venom of Crotalus durissus durissus has 
also been reported by Gutierrez et al. (32). The study also investi-
gated proteolytic and hemorrhagic activities, both of which were 
evident in C. d. durissus venom. It was also found that the crude 
venom exhibited an i.v. LD50 of 31.2 ± 3.4 µg. 
Bolanos et al. (33) has studied 149 snakebite cases from the 
Pacific region of Costa Rica. It was found that 14% of these could 
be attributed to Crotalus durissus durissus. No neurological signs, 
alterations in the blood pressure or renal complications were found in 
even the most severe cases; however, the victims did show symptoms of 
pain, edema, local temperature, mild bleeding, and local necrosis and 
alteration of the blood coagulation test. 
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CHAPTER III 
EXPERIMENTAL PROCEDURES 
A, Materials 
Crude, lyophilized Crotalus durissus durissus venom was obtained 
from the Miami Serpentarium Laboratories, Miami, Fl., as was crude, 
lyophilized Crotalus viridis viridis venom from which myotoxin ~ was 
purified. Sephadex G-50 and G-75 gel filtration gels, carboxymethyl 
Sephadex C-25 cation exchange gel, protein standards, polyacrylamide 
monomer, and benzoylated dialysis tubing were obtained from Sigma 
Chemical Co., St. Louis, Mo. TRIS and KCl were obtained from Fisher 
Scientific Co., Chemical Manufacturing Division, Fair Lawn, N.J. Gel 
filtration columns and associated equipment were obtained from Glenco 
Scientific, Inc., Houston, Tx,, and constructed in the OSU glass shop, 
B. Sephadex G-75 Gel Filtration 
Initial fractionation of crude Crotalus durissus durissus venom 
was performed using a Sephadex G-75 gel filtration column. Aliquots 
of 200 mg of the venom were dissolved in 1 ml of an elution buffer 
consisting of 0.05 M TRIS at pH 10 and 0.1 M KCl. This was loaded onto 
a Sephadex G-75 gel filtration column (1.5 x 110 cm), equilibrated with 
the elution buffer. 0 All fractionation steps were performed at 2-4 C 
in a walk-in cold room, The column was developed at a flow rate of 
4.0 ml/hr and 2.5 ml fractions were collected on an Instrumentation 
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Specialties Co. Model 1200 fraction collector. Absorbance of each 
tube was measured at 280 nm on a Perkin-Elmer Coleman 101 spectro-
photometer. Appropriate tubes for each fraction were pooled and 
lyophilized. The fractions were then placed in benzoylated dialysis 
bags (molecular weight limit of 2000 daltons) and desalted by dialysis 
against distilled water under stirring for 24 hrs. These fractions 
were lyophilized, weighed, and stored at -20°c. 
C. Cation Exchange Chromatography 
G-75 fractions 3 and 4 were further fractionated independently 
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by cation exchange chromatography according to the following procedure: 
The respective desalted, lyophilized G-75 fraction was dissolved in 
1 ml of an elution buffer of 0.1 M KCl/0.05 M TRIS (pH 10) and applied 
to a carboxymethyl Sephadex C-25 cation exchange column equilibrated 
with the same buffer. The column was developed with a flow rate of 
0.3 ml/min with a three-step continuous KCl salt gradient from 0.1 M-
2.0 M in the 0.05 M TRIS (pH 10) buffer system. Fractions of 2.5 ml 
were collected on an Instrumentation Specialties Co. model 1200 
fraction collector. Determination of the absorbance of each tube at 
280 nm was performed on a Perkin-Elmer Coleman 101 spectrophotometer, 
and the conductivity of each tube measured on a London type COM2d 
conductivity meter, The tubes corresponding to each fraction were 
pooled and lyophilized. These fractions were then dialyzed against 
distilled water under stirring for 24 hrs using benzoylated dialysis 
tubing. The desalted fractions were then lyophilized, weighed, and 
stored at -20°c until used in further tests. 
D. Assay for Myotoxicity 
Assays for myonecrotic activity on the crude venom and fractions 
thereof were performed by the method of Ownby et al. (15). 20-24 
gram Swiss Webster white mice were injected in the medial aspect of 
the thigh with 2.5 µg per gram body weight of the crude venom or 
fractions in physiological saline (0,085% NaCl w/v). Controls were 
injected only with physiological saline. The animals were sacrificed 
at 24 hrs by cervical dislocation, and cubical tissue samples of 
approximately 1 mm per side were taken from the opposite side of the 
injected area to avoid any damage arising from injection. The samples 
were immediately fixed in 2% glutaraldehyde for 2 hrs, followed by 
fixing in 1% osmium tetraoxide for one hour. Dehydration was accom-
plished by immersion of the tissue in increasing concentrations of 
acetone, followed by propylene oxide overnight. The tissue was then 
embedded in Poly/Bed 812, and allowed to polymerize at 60°C in a 
vacuum oven, The embedded tissue was subsequently sectioned into 
1 µm sections on an LKB Ultra Microtome, and stained with Mallory's 
Ozure II methylene blue. Photographs were taken on a Zeiss photo~ 
microscope using a tungsten light source. 
E. Disc Polyacrylamide Gel Electrophoresis 
Disc polyacrylamide gel electrophoresis at pH 4.3 was performed 
by the method of Reisfeld et al. (34), with the compositions of the 
gel components as follows: 
STACKING GEL: 5% acrylamide, 1.25% BIS, 0.5% riboflavin, 
0.24 ml 1 N KOH, 0.014 ml glacial acetic acid, 0,0023 ml 
TEMED/4 ml stacking gel solution. 
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RESOLVING GEL: 15% acrylamide, 0.1% BIS, 0.1% ammonium 
persulfate, 0.72 ml 1 N KOH, 0.258 ml glacial acetic 
acid, 0.06 ml TEMED/12 ml resolving gel solution. 
SAMPLE SOLUTION: 5 µl 2.7% KOH/2.9% glacial acetic acid 
solution; 5 µl 0.005% bromophenol blue solution; 10 µl 
40% sucrose solution; 20 µl sample liquid. 
The gels were electrophoresed with a Buchler 3-1500 power source 
at 4 m.A/tube for 3 hours, and were stained immediately following 
electrophoresis with 0.5% aniline blue black in 7% acetic acid for 
30 min, and destained in 7% acetic acid, The gels were scanned on 
a Helena Laboratories Auto Scanner, 
F. Slab Polyacrylamide Gel Electrophoresis 
Slab polyacrylamide gel electrophoresis was performed using the 
pH 4.3 system of Reisfeld et al. (34), with the slab technique 
described by Ames et al. (35). The composition of the gel components 
was as follows: 
STACKING GEL: 5% acrylamide, 1.25% BIS, 0.5% riboflavin, 
0.24 ml 1 N KOH, 0.014 ml glacial acetic acid, 0.0023 ml 
TEMED/4 ml stacking gel solution. 
RESOLVING GEL: 15% acrylamide, 0,1% BIS, 0.1% ammonium 
persulfate, 0.72 ml 1 N KOH, 0.258 ml glacial acetic acid, 
0.06 ml TEMED/12 ml resolving gel solution. 
SAMPLE SOLUTION: 5 µl 2.7% KOH/2.9% glacial acetic acid 
solution; 5 µl 0.005% bromophenol blue solution; 10 µl 
40% sucrose solution; 20 µl sample liquid. 
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The slab gel was electrophoresed in a Protean Slab Electrophoresis 
Cell by BioRad at 20 ma for l~ hrs followed by 40 ma for 5 hrs, stained 
immediately with 0.5% analine blue black in 7% acetic acid for 30 min, 
followed by destaining in 7% acetic acid. 
G. Amino Acid Analysis 
Amino acid compositions were determined by the method of Moore 
and Stein (36). Hydrolysis was performed with 6 N HCl at no0 c for 
24, 48, and 72 hrs. Analysis was accomplished using a Beck.man Model 
120 C automatic amino acid analyzer modified by the method of Liao 
et al. (37). Myotoxin ~was also hydrolyzed in the same manner and 
used as a reference. The values for half-cystine were calculated by 
extrapolation to zero time. 
H. SDS Gel Electrophoresis 
SDS slab gel electrophoresis was performed by the method of 
Laemmli et al. (38). The composition of the gel components were as 
follows: 
RESOLVING GEL (pH 8.8): 3.6 ml 1 N HCl, 2,7 g TRIS, 0.017 
ml TEMED, 4.2 g acrylamide, 0.11 g BIS, 0.3 ml 10% SDS, 
0.01 g ammonium persulfate/29.8 ml resolving gel solution. 
STACKING GEL (pH 6.8): 1.2 ml 1 N HCl, 0.15 g TRIS, 0.012 
ml TEMED, 0.7 g acrylamide, 0.018 g BIS, 0.2 ml 10% SDS, 
0.0035 g ammonium persulfate/7.7 ml stacking gel solution. 
The proteins were electrophoresed in a 15% gel at pH 8.9 at 10 mA 
for two hrs, followed by 20 mA for four hrs on a Bio-Rad Protean 
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electrophoresis cell. Protein standards used were bovine serum albumin 
(66 kdal), ovalburnin (45 kdal), carbonic anhydrase (31 kdal), chyrno-
trypsinogen (25 kdal), soybean trypsin inhibitor (21.5 kdal), ribonu-
clease A (13.7 kdal), lysozyrne (14.4 kdal), insulin (5,7 kdal) and 
myotoxin ::_ (4.6 kdal). The gel was fixed in a solution containing 10% 
acetic acid and 25% isopropanol; stained with a 0.02% coomassie blue 
7% acetic acid solution; and destained with a solution containing 25% 
methanol and 10% acetic acid. 
Molecular weights were estimated by the construction of a graph 
plotting log of molecular weight vs. relative mobility. 
I. Sephadex G-50 Gel Filtration 
Molecular weight of the toxins were estimated by a Sephadex G-50 
gel filtration column (100 x 1.5 cm) by the method of Andrews et al. 
(39), using a buffer with 0.05 M TRIS (pH 10) and 0.1 M KCl. Poly-
peptide standards used were chymotrypsinogen a (23.2 kdal), cytochrome 
c (12.4 kdal), salamine (7 kdal), myotoxin ~ (4.6 kdal) and clupeine 
(4 kdal). The void volume was marked with Dextran Blue. From the 
elution profile obtained, a graph plotting log of molecular weight vs. 
the ratio of the elution volume over the void volume was constructed, 
and the appropriate molecular weights of the toxins were calculated 
from their respective elution volumes. 
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CHAPTER IV 
RESULTS AND DISCUSSION 
A. Isolation of Venom Myotoxins 
The isolation of myotoxins I and II from crude Crotalus durissus 
durissus venom appears in Figure 1. From the initial fractionation 
of the venom on a Sephadex G-75-40 gel filtration column, six peaks 
were obtained, as shown in the elution profile in Figure 2. These 
peaks represent fractions 1 through 6. Fraction 3 from Sephadex G-75 
was further fractionated on a CMS cation exchange column, with 
resolution into three peaks, shown in Figure 3. Fraction 3C from CMS 
proved to be essentially homogeneous by electrophoresis and displayed 
myonecrotic activity, and was termed myotoxin I. 
Fraction 4 from Sephadex G-75 was also subjected to cation 
exchange chromatography, resulting in its separation into four peaks, 
as seen in Figure 4. CMS fraction 4D, after demonstrating myonecrotic 
activity and homogeneity by electrophoresis was named myotoxin II. The 
relative composition of the venom with respect to each fraction and the 
two myotoxins is summarized in Table I. The active myotoxic fractions 
3 and 4 from the Sephadex fractionation represents 4 and 26%, respec-
tively, of the crude venom. Myotoxins I and II are minor constituents 
of this venom, and are not neutralized by the antisera presently 
commercially available ·(40). However, Ownby (41) reports that the 
myonecrotic components in Crotalus durissus durissus venom react with 
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Fraction 
1 
Fraction 
3A. 
Fraction 
2 
Fraction 
3B 
Crude Venom 
Sephadex G-75-40 !Gel Filtration 
Fraction 
3 
Fraction 
4 
desalted, lyophilized 
Sephadex C-25-120 Cation Exchange 
Fraction 
3C 
Fraction 
4A 
Fraction 
4B 
Fraction 
5 
Fraction 
4C 
desalted, lyophilized 
Myotoxin I 
Fraction 
6 
Fraction 
4D 
Myotoxin II 
Figure 1. Isolation Procedure of Myotoxins I and II from Crotalus durissus durissus 
Venom. 
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Figure 2. Sephadex G-75 Elution Profile of Crotalus durissus 
durissus Venom. 
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Figure 3. Sephadex C-25 Cation Exchange Chromatography of Sephadex 
G-75 Fraction 3. 
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Marked peak indicates the fraction composed of myotoxin I. 
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Figure 4. Sephadex C-25 Cation Exchange Chromatography of Sephadex 
G- 75 Fraction 4. 
Marked peak indicates the fraction composed of myotoxin 
II. 
TABLE I 
DISTRIBUTION OF PROTEIN AND MYONECROSIS OF FRACTIONS FROM 
SEPHADEX G-75 AND C-25 FRACTIONATION OF 
CROTALUS DURISSUS DURISSUS VENOM 
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Fractional Step Fraction M . 1 yonecrosis % of Protein 
in Crude Venom 
G-75 Gel Filtration 1 6,2 
2 37,2 
3 +I- 3.9 
4 -H+ 26.2 
5 25.6 
6 0.9 
C-25 Ion Exchange 3A 3.2 
3B + 0.2 
3C +I- 0.5 
4A 7.6 
4B 2.2 
4C + 0.4 
4D -H+ 15.9 
1 Legend: (-) = No evidence of myonecrosis; (+) = mild myonecrosis; 
(+I-) = moderate myonecrosis; (-H+) = severe myonecrosis. 
antimyotoxin ~ (produced in rabbits) and identify completely in gel 
diffusion with myotoxin ~ and crotamine. 
B. Identification of Myonecrotic Activity 
The results of the assays for myonecrosis performed on the crude 
venom, as well as on the various fractions and subfractions, is shown 
in Table I. Muscle tissue removed from an animal injected with crude 
venom is shown in Figure 5, which can be compared to tissue injected 
only with PSS in Figure 6. 
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It can be seen from these photographs that crude Crotalus durissus 
durissus venom induces massive hemorrhage, seen as small dark points, 
which are erythrocytes which have escaped the surrounding capillaries. 
Figure 5 also shows large areas of necrosis, as demonstrated by the 
vacuolization of the individual muscle cells. 
From Table I it can be seen that both fractions 3 and 4 show 
strong myonecrotic activity. Therefore, these fractions were further 
fractionated and the subfractions assayed for myonecrotic activity. 
In the testing of subfractions 3A-3C and 4A-4D, it was discovered 
that fractions 3C and 4D contained the higher activities. The small 
degree of necrosis arising from fractions 3B and 4C is considered to 
result from some overlap with fractions 3C and 4D, respectively. 
Figures 7 and 8 show tissue from animals injected with myotoxins 
I and II. These can be compared to the activity of myotoxin a from 
Crotalus viridis viridis appearing in Figure 9. The lack of erythro-
cytes in these photographs indicate that myotoxins I and II are not 
responsible for the hemorrhagic activity shown by the crude venom. 
The large areas of vacuolization of cell nuclei are readily apparent 
Figure 5. Photomicrograph of Muscle Tissue Injected 
with Crude Crotalus durissus durissus 
Venom. 
Arrow A points to muscle cell which has 
been destroyed as a result of myonecrotic 
components present in the crude venom. 
Arrow B points to erythrocytes that have 
escaped through nearby capillaries. 
(Tissue magnified 192 times.) 
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Figure 6. Photomicrograph of Muscle Tissue from 
Control Animal Injected with Physio-
logical Saline. 
Arrow points to normal muscle cell. 
(Tissue magnified 192 times.) 
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Figure 7. Photomicrograph of Muscle Tissue Injected 
with Purified Myotoxin I. 
Arrow points to damaged muscle cell. 
Lighter areas in cell are vacuoles 
formed as the result of the action 
of myotoxin I. (Tissue magnified 192 
times.) 
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Figure 8. Photomicrograph of Muscle Tissue Injected 
with Purified Myotoxin II. 
Arrow points to cell which shows the 
extreme vacuolization characteristic of 
rattlesnake myonecrotic toxins. (Tissue 
magnified 480 times.) 
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fl.SC! 
Figure 9. Photomicrograph of Muscle Tissue Injected 
with Myotoxin a from Crotalus viridis 
viridis. -
Arrow points to a group of necrotic cells 
which are indistinguishable from cells 
damaged by myotoxins I and II from 
Crotalus durissus durissus venom on the 
light microscope level of investigation. 
(Tissue magnified 192 times.) 
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in each of these photographs, and have proved to be indistinguishable 
from myotoxin a on the light microscopy level of investigation. 
C. Electrophoretic Homogeneity 
Demonstration of the homogeneity of myotoxins I and II was 
determined by disc polyacrylamide gel electrophoresis in a 15% gel at 
pH 4.3. Figure 10 shows a scan of a gel with myotoxin I as the sample 
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compared with a gel containing myotoxin ~ from Crotalus viridis viridis 
venom. Myotoxin I shows relative homogeneity with noticeable but minor 
contaminates. This figure also points out a great deal of chemical 
similarity between myotoxin I and myotoxin a. Figure 11 shows the 
same experiment repeated with myotoxin II. Again, the protein appears 
relatively pure, and indicates similar chemical properties to myotoxin 
a. 
Figure 12 shows the results of slab polyacrylamide gel electro-
phoresis performed with myotoxins I and II. This was also accomplished 
in the 15% gel system at pH 4.3. This experiment confirms the fact 
that myotoxin I and myotoxin II are distinct proteins, with differing 
migration properties. It can be seen from this gel that myotoxin II 
migrates further than myotoxin I, which is in good agreement with other 
data collected, in that myotoxin II is of lower molecular weight than 
myotoxin I, and also possess a higher charge/mass ratio. 
D. Amino Acid Compositions of Toxins I and II 
The results of the amino acid analysis of toxins I and II are shown in 
Tables II and III, respectively. Myotoxin I was found to consist of 42 amino 
acid residues. It was found that it contained a high number of basic 
·A - B c D E 
~~ ~.~ ~<i :\-~ fl 2 ~"'"' ..... 
'Rt ~~ I "> I ~,:. ti t1: ~ 
't t ... - 11' .... t~ 
Figure 10. Slab Polyacrylamide Gel Electrophoresis 
of Purified Myotoxins I and II. 
Lanes A and B contain myotoxin !!: from 
Crotalus viridis. viridis venom; Lanes 
C and D contain myotoxin II and Lane 
E myotoxin I, both from Crotalus 
durissus durissus venom. 
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Figure 11. Scan of Disc Polyacrylamide Gel Electrophoresis of Purified Myotoxin I. 
LU 
0 
PAGE-15%, pH 4.3 
+ 
myo'a' 
C.d.d.II 
Figure 12. Scan of Disc Polyacrylamide Gel Electrophoresis of Purified Myotoxin II. 
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TABLE II 
AMINO ACID COMPOSITION OF MYOTOXIN 11 •2 
Amino Acid 3 Corrected Value Nearest Integer 
asx 2.95 3 
thr 1.11 1 
ser 5.68 6 
glx 2.96 3 
pro 2.12 2 
gly 4.91 5 
ala 1.44 1 
~-cys 6.30 6 
val 1. 39 1 
met 0.68 1 
ile 1.10 1 
leu 1.07 1 
tyr 0.76 1 
phe 1.18 1 
his 1. 76 2 
lys 5.89- 6 
arg 1.08 1 
Total 42 
1Analysis based on comparison to myotoxin ~· 
2Tryptophan not determined. 
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Weight 
345 
101 
522 
387 
194 
285 
71 
618 
99 
131 
113 
113 
163 
147 
274 
768 
156 
4487 
3The value for ~ cystine was corrected by extrapolation to zero time; 
average values are given for all other amino acids. 
TABLE III 
AMINO ACID COMPOSITION OF MYOTOXIN II1 •2 
Amino Acid 3 Corrected Value Nearest Integer 
asx 2.89 
thr 0.76 
ser 2.51 
glx 1.18 
pro 1.60 
gly 2.74 
ala 0.58 
~-cys 6.35 
val 1.80 
met 0.79 
ile 0.90 
leu 0.89 
tyr 0.74 
phe 1. 36 
his 1. 38 
lys 5.91 
arg 1.17 
Total 
1Analysis based on comparison to myotoxin ~· 
2 Tryptophan not determined. 
3 
1 
3 
1 
2 
3 
1 
6 
2 
1 
1 
1 
1 
1 
1 
6 
1 
35 
33 
Weight 
345 
101 
261 
129 
194 
171 
71 
618 
198 
131 
113 
113 
163 
147 
137 
768 
156 
3816 
3The value for 1z cystine was corrected by extrapolation to zero time; 
average values are given for all other amino acids. 
residues and six half·cystine residues. 
Myotoxin II was found to be composed of 35 amino acids. It also 
contains a high percentage of basic amino acids, and has six half-
cystine residues. 
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Due to the small amount of myotoxins I and II available, analysis 
for tryptophan was not performed. 
E. Molecular Weight Estimates 
The results of an SDS slab gel electrophoresis procedure performed 
with myotoxin I appears in Figure 13. From this data, it can be seen 
that myotoxin I shows a molecular weight of approximately 8500. How-
ever, myotoxin ~ from Crotalus viridis viridis venom with a known 
molecular weight of 4600 also shows a similar migration distance. 
This is thought to arise from the inability of the SDS molecules 
to completely neutralize the excess positive charges in these molecules 
which arises from their high content of basic amino acid residues. 
This would result in a retarded migration rate for the molecules, 
accounting for the discrepancy in molecular weights. Due to these 
results, the experiment was not repeated with myotoxin II. 
The molecular weights of the myotoxins were also determined by 
Sephadex G-50-40 gel filtration. The column was calibrated, and 
myotoxins I and II were separately loaded on the column and their 
elution volumes determined. Figure 14 shows the calibration plot 
obtained. It can be seen from this figure that myotoxin I shows a 
molecular weight of 5500, and myotoxin II a molecular weight of 4500. 
Minimum molecular weights are also obtainable from the amino 
acid compositions of myotoxins I and II. From this data, molecular 
100 
10 
1 
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& Myotoxin 2_ 
RELATIVE MOBILITY 
0.7 
Figure 13. Molecular Weight Determination of Myotoxin I 
by SDS Gel Electrophoresis. 
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Figure 14. Molecular Weight Determination of Myotoxins I and II by 
Sephadex G-50 Gel Filtration. 
Uncertainty in Ve/V0 indicated by lengths of dat_a bars. 
As can be seen, only clupeine deviated substantially 
from the standardization curve. 
weights of 4487 and 3816 were calculated for myotoxins I and II, 
respectively. 
F. Comparison of Myotoxin I and II with 
Other Rattlesnake Myotoxins 
A summary of the previously characterized rattlesnake myonecrotic 
proteins appears in Table IV, as well as the data compiled from this 
work. It can be seen that all of these toxins, with the exception of 
viriditoxin, have several strong similarities. First, the molecular 
weights all span the narrow range from 3700-4700. Secondly, all 
37 
have unusually high lysine contents, with few arginine residues present, 
All of these toxins for which a value has been reported possess 6 half 
cystine residues, with myotoxin !!t crotamine, and the myotoxin from 
Crotalus viridis helleri known to possess three disulfide bridges. 
This indicates a great similarity of their three-dimensional structures, 
undoubtedly related to the mechanism of their biological actions. 
Since the work done in this area to date is limited and incom-
plete, it is impossible to make distinctions between these various 
proteins/polypeptides. It is clear though, that these molecules as 
a whole represent an entirely new class of biological compounds, 
unique not only in their structure, but their function as well. 
TABLE IV 
COMPARATIVE DATA OF MYONECROTIC PROTEINS FROM RATTLESNAKE VENOMS 
Source Name MW pl No. of Disulfide Amino Acids Bridges 
_f, viridis viridis Myotoxin ~ 4600 9.2 42 3 
Viriditoxin 115000 4.8 1018 
Q.. durissus terrificus Crotamine 4600 >9.0 42 3 
C. viridis concolor Myotoxin I >9.0 35 
Myotoxin II >9.0 39 
C. viridis helleri 4700 43 3 
C. durissus durissus Myotoxin I 4500 42 
Myotoxin II 3800 35 
Reference 
11 
24 
21 
23 
8 
Present 
Inves. 
l;J 
00 
CHAPTER V 
SUMMARY 
It was the prestated objective of this work to isolate and charac-
terize the myonecrotic components of Crotalus durissus durissus venom. 
During the course of this study, two myonecrotic toxins were 
identified and isolated. These myotoxins have been found to be of 
low molecular weight, and show a great deal of physical and chemical 
similarities to previously isolated and characterized polypeptides that 
demonstrate the same biological activities. 
Myotoxin I from Crotalus durissus durissus venom has been shown 
to possess a minimum molecular weight of 4487, and composed of a 
minimum of 42 amino acid residues. These include six lysines, which 
greatly effect the behavior of the molecule. Also present are six 
half-cystine residues, making possible the existence of three disulfide 
bridges. Both of these characteristics are present in several of the 
well characterized myonecrotic polypeptides occurring in rattlesnake 
venoms (21). 
Myotoxin II from Crotalus durissus durissus venom demonstrates a 
minimum molecular weight of 3816, with a minimum of 35 amino acid 
residues. It also possesses six lysine residues, had has six half-
cystines. Although smaller than myotoxin I, and the two best charac-
terized rattlesnake basic myotoxins (myotoxin ~ from Crotalus viridis 
viridis and crotamine from Crotalus durissus terrificus), its smaller 
39 
40 
size is not unprecedented (23). 
Both of these toxins have demonstrated strong myonecrotic 
activities. Their injection into test animals has resulted in severe 
vacuolization of muscle cells indistinguishable from myotoxin ~ and 
crotamine on the light microscopy level of investigation. 
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